DEVELOPMENT OF UV-SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF IMATINIB MESYLATE (ITM) IN BULK AND FORMULATION
A simple and precise spectroscopic method for determination of Imatinib Mesylate in its bulk and tablet dosage forms has been developed and validated. This methodÂ based upon measurement of light absorption in UV region. The UV spectra of Imatinib Mesylate showed that maximum absorbance of light was observed at 281 nm and linearity was observed in the concentration range of 2-28ug/ml with correlation coefficient 0.999. The proposed method was validated as per ICH Q2 (R1) guidelines for linearity, accuracy, precision and recovery. The limit of detection (LOD) and limit of quantitation (LOQ) were found to be 0.040468 (Î¼g/ml) and 0.122263 (Î¼g/ml) respectively by simple UV Spectroscopy.
Martindale: The complete drug reference. 36th edition, Pharmaceutical press, Lambeth High Street, London. 2009; 773-774.
Widmer et al. Determination of imatinib in human plasma by solid-phase extractionâ€“liquid Chromatographyâ€“ultraviolet absorbance detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004; 803(2): 285-92.
Thirumurthy et al. Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of Imatinib in biological samples. J. of Chromatography B. 2004; 804, 2(25):431-434.
Vivekanand et al. A validated LC method for imatinib mesylate Journal of pharmaceutical andbiomedical analysis, 200; 333(5): 879-889.
Ivanovic, D., Medenica, M., Jancic B. and Malenovic, A., Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glive capsules. J. chromatography B. 2004; 800 (1-2): 253-258.
Roos, LO., Jos, HB., Jan HM.,Olaf van, T. Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed phase high-performance liquid chromatography. Biomedical chromatography 2007; 21(7):747-754.
Solassol, F., Bressolle, L., Philibert, V., Charasson, C., Astre, F.Liquid Chromatography- Electrospray Mass Spectrometry Determination of Imatinib and Its Main Metabolite, N-Desmethyl- Imatinib in Human Plasma. J. liquid chromatography and related technologies. 2006;29 (20): 2957-2974.
Rosasco et al. Validation of an HPLC Method for the Determination of Imatinib Mesylate in Pharmaceutical Dosage forms. J. liquid chromatography and related technologies, 2005;28 (20): 3283-3292.
Satyanarayana et al. Development and Validation of New Reversed Phase High Performance Liquid Chromatography Method for the Estimation of Imatinib in Bulk and Pharmaceutical Dosage Forms. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2010; Vol. 1 (1): 6-9
Bende, G., Kollipara, S., Sekar, V. and Saha, R. UV-spectrophotometric determination of Imatinib mesylate and its application in solubility studies.Die pharmazie, 2008; 63(9): 641-645.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.